Vulnerability in Oracle Application Testing Suite (component: OpenScript). The supported version that is affected is 13.3.0.1. Easily exploitable vulnerability allows low privileged attacker with logon to the infrastructure where Oracle Application Testing Suite executes to compromise Oracle Application Testing Suite. Successful attacks of this vulnerability can result in takeover of Oracle Application Testing Suite. CVSS 3.1 Base Score 7.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).
Advisories
No advisories yet.
Fixes
Solution
No solution given by the vendor.
Workaround
No workaround given by the vendor.
References
| Link | Providers |
|---|---|
| https://www.oracle.com/security-alerts/cspunov2026.html |
|
History
Tue, 17 Nov 2026 21:45:00 +0000
| Type | Values Removed | Values Added |
|---|---|---|
| Description | Vulnerability in Oracle Application Testing Suite (component: OpenScript). The supported version that is affected is 13.3.0.1. Easily exploitable vulnerability allows low privileged attacker with logon to the infrastructure where Oracle Application Testing Suite executes to compromise Oracle Application Testing Suite. Successful attacks of this vulnerability can result in takeover of Oracle Application Testing Suite. CVSS 3.1 Base Score 7.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H). | |
| First Time appeared |
Oracle
Oracle application Testing Suite |
|
| CPEs | cpe:2.3:a:oracle:application_testing_suite:13.3.0.1:*:*:*:*:*:*:* | |
| Vendors & Products |
Oracle
Oracle application Testing Suite |
|
| References |
| |
| Metrics |
cvssV3_1
|
Projects
Sign in to view the affected projects.
Status: PUBLISHED
Assigner: oracle
Published:
Updated: 2026-11-17T21:31:35.228Z
Reserved: 2026-10-22T04:13:03.111Z
Link: CVE-2026-114861
No data.
Status : Received
Published: 2026-11-17T22:18:14.693
Modified: 2026-11-17T22:18:14.693
Link: CVE-2026-114861
No data.
OpenCVE Enrichment
No data.
Weaknesses
No weakness.